Search

everythinglearnresearchcommunity

for

Search:↓

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.